Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection

Sînziana Daia-Iliescu,Ruxandra Ionescu,Daniela Opriş,Bogdan Toia

doi:10.1186/1471-2334-14-s7-p73

Abstract

Background Treating chronic HCV/HBV-infected patients with concomitant rheumatoid arthritis (RA) may be a challenge to the clinician. The liver disease limits to some degree the treatment for the rheumatic disease as the drugs used are hepatotoxic or at risk of infection reactivation. The aim of the study is to evaluate the particularities and the safety of RA treatment in patients with both conditions and to investigate the prevalence of HBV/ HCV-infections in RA patients.

Highlights

Treating chronic HCV/HBV-infected patients with concomitant rheumatoid arthritis (RA) may be a challenge to the clinician
We performed a cross-sectional analysis of all HCV/HBV or co-infected patients with concomitant RA admitted between 2009-2014, assessing the clinical, laboratory, treatment data and verifying the statistic correlations
* Correspondence: daia.sanziana@gmail.com 1“Sf. Maria” Clinical Hospital, Bucharest, Romania Full list of author information is available at the end of the article patients sulphasalazine alone

Summary

Introduction

Treating chronic HCV/HBV-infected patients with concomitant rheumatoid arthritis (RA) may be a challenge to the clinician. Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection Background Treating chronic HCV/HBV-infected patients with concomitant rheumatoid arthritis (RA) may be a challenge to the clinician. The liver disease limits to some degree the treatment for the rheumatic disease as the drugs used are hepatotoxic or at risk of infection reactivation.

Objectives

Results

Conclusion